Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8974)
All Articles published online
|
Publishing Process of This Article
|
Aug 8, 2015 (publication date) through Nov 5, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Facciorusso A, Licinio R, Muscatiello N, Di Leo A, Barone M. Transarterial chemoembolization: Evidences from the literature and applications in hepatocellular carcinoma patients. World J Hepatol 2015; 7(16): 2009-2019 [PMID: 26261690 DOI: 10.4254/wjh.v7.i16.2009] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v7/i16/2009.htm |
| Number | Citing Articles |
| 1 |
Mina S. Makary, Umang Khandpur, Jordan M. Cloyd, Khalid Mumtaz, Joshua D. Dowell. Locoregional Therapy Approaches for Hepatocellular Carcinoma: Recent Advances and Management Strategies. Cancers 2020; 12(7): 1914 doi: 10.3390/cancers12071914
|
| 2 |
Roberto Mazzanti, Umberto Arena, Renato Tassi. Hepatocellular carcinoma: Where are we?. World Journal of Experimental Medicine 2016; 6(1): 21-36 doi: 10.5493/wjem.v6.i1.21
|
| 3 |
Shou-Wu Lee, Teng-Yu Lee, Yu-Chi Cheng, Chieh-Ling Yen, Sheng Shun Yang. The correlation with tumor radiological characteristics and prognosis of patients with early-stage hepatocellular carcinoma receiving transcatheter arterial chemoembolization. Medicine 2021; 100(26): e26414 doi: 10.1097/MD.0000000000026414
|
| 4 |
Alessandro Granito, Antonio Facciorusso, Rodolfo Sacco, Laura Bartalena, Cristina Mosconi, Ugo Vittorio Cea, Alberta Cappelli, Matteo Antonino, Francesco Modestino, Nicolò Brandi, Francesco Tovoli, Fabio Piscaglia, Rita Golfieri, Matteo Renzulli. TRANS-TACE: Prognostic Role of the Transient Hypertransaminasemia after Conventional Chemoembolization for Hepatocellular Carcinoma. Journal of Personalized Medicine 2021; 11(10): 1041 doi: 10.3390/jpm11101041
|
| 5 |
Amar Karalli, Johan Teiler, Mojgan Haji, Elin Seth, Torkel B. Brismar, Staffan Wahlin, Rimma Axelsson, Per Stål. Comparison of lipiodol infusion and drug-eluting beads transarterial chemoembolization of hepatocellular carcinoma in a real-life setting. Scandinavian Journal of Gastroenterology 2019; 54(7): 905 doi: 10.1080/00365521.2019.1632925
|
| 6 |
Thomas Couri, Anjana Pillai. Goals and targets for personalized therapy for HCC. Hepatology International 2019; 13(2): 125 doi: 10.1007/s12072-018-9919-1
|
| 7 |
Juanfang Liu, Shanshan Xie, Xuhua Duan, Jianjian Chen, Xueliang Zhou, Yahua Li, Zhaonan Li, Xinwei Han. Assessment of efficacy and safety of the transcatheter arterial chemoembolization with or without apatinib in the treatment of large hepatocellular carcinoma. Cancer Chemotherapy and Pharmacology 2020; 85(1): 69 doi: 10.1007/s00280-019-04004-z
|
| 8 |
Ze-Feng Zhang, Yu-Jun Luo, Quan Lu, Shi-Xue Dai, Wei-Hong Sha. Conversion therapy and suitable timing for subsequent salvage surgery for initially unresectable hepatocellular carcinoma: What is new?. World Journal of Clinical Cases 2018; 6(9): 259-273 doi: 10.12998/wjcc.v6.i9.259
|
| 9 |
Brian A. Scansen. Interventional Radiology. Veterinary Clinics of North America: Small Animal Practice 2016; 46(3): 535 doi: 10.1016/j.cvsm.2015.12.009
|
| 10 |
Nina Samuel, Chick Weisse, Allyson C. Berent, Cléo P. Rogatko, Luke Wittenburg, Kenneth Lamb. Pharmacokinetic study comparing doxorubicin concentrations after chemoembolization or intravenous administration in dogs with naturally occurring nonresectable hepatic carcinoma. Journal of Veterinary Internal Medicine 2022; 36(5): 1792 doi: 10.1111/jvim.16520
|
| 11 |
Stavros Spiliopoulos, Ornella Moschovaki-Zeiger, Akshay Sethi, George Festas, Lazaros Reppas, Dimitris Filippiadis, Nikolaos Kelekis. An update on locoregional percutaneous treatment technologies in colorectal cancer liver metastatic disease. Expert Review of Medical Devices 2023; 20(4): 293 doi: 10.1080/17434440.2023.2185137
|
| 12 |
Brian I. Carr, Srikanth Nagalla, Ravit Geva. Hepatocellular Carcinoma. 2016; : 489 doi: 10.1007/978-3-319-34214-6_33
|
| 13 |
Thierry de Baere, Maxime Ronot, Jin Wook Chung, Rita Golfieri, Roman Kloeckner, Joong-Won Park, Bernhard Gebauer, Nabil Kibriya, Ganapathy Ananthakrishnan, Shiro Miyayama. Initiative on Superselective Conventional Transarterial Chemoembolization Results (INSPIRE). CardioVascular and Interventional Radiology 2022; 45(10): 1430 doi: 10.1007/s00270-022-03233-9
|
| 14 |
Cao-ye Wang, Jin-guo Xia, Zheng-qiang Yang, Wei-zhong Zhou, Wen-hua Chen, Chun-jian Qi, Jian-ping Gu, Qi Wang. Transarterial chemoembolization with medium-sized doxorubicin-eluting Callisphere is safe and effective for patients with hepatocellular carcinoma. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-61209-6
|
| 15 |
Rifqi Yanda Muhammad, Derri Hafa Nurfajri, Dahril Dahril, Jufriady Ismy. Survival rate comparisons of angioembolization and neoadjuvant targeted therapy on unresectable renal cell carcinoma patients: A systematic review. Urology Annals 2024; 16(4): 251 doi: 10.4103/ua.ua_114_23
|
| 16 |
Jun Deng, Feng Wen. Transarterial Chemoembolization Combined With Tyrosine Kinase Inhibitors for Intermediate‐Stage Hepatocellular Carcinoma, What Else Can We Do?. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.824799
|
| 17 |
Yan Zhang, Mei-Wu Zhang, Xiao-Xiang Fan, Da-Feng Mao, Quan-Hua Ding, Lu-Hui Zhuang, Shu-Yi Lv. Drug-eluting beads transarterial chemoembolization sequentially combined with radiofrequency ablation in the treatment of untreated and recurrent hepatocellular carcinoma. World Journal of Gastrointestinal Surgery 2020; 12(8): 355-368 doi: 10.4240/wjgs.v12.i8.355
|
| 18 |
Pierpaolo Biondetti, Lorenzo Saggiante, Anna Maria Ierardi, Massimo Iavarone, Angelo Sangiovanni, Filippo Pesapane, Enrico Maria Fumarola, Pietro Lampertico, Gianpaolo Carrafiello. Interventional Radiology Image-Guided Locoregional Therapies (LRTs) and Immunotherapy for the Treatment of HCC. Cancers 2021; 13(22): 5797 doi: 10.3390/cancers13225797
|
| 19 |
Shen Zhengjie, Gu Wenzhe, Cheng Haibo, Shen Weixing, Sun Dongdong, Zeng Yun, Tao Lihuiping, Wu Mianhua. Effect of Aidi injection plus transarterial chemoembolization on primary hepatic carcinoma: a systematic review and Meta-analysis. Journal of Traditional Chinese Medicine 2017; 37(5): 567 doi: 10.1016/S0254-6272(17)30310-2
|
| 20 |
Junwei Chen, Lisha Lai, Churen Zhou, Junyang Luo, Haofan Wang, Mingan Li, Mingsheng Huang. Safety, efficacy, and survival of drug-eluting beads-transarterial chemoembolization vs. conventional-transarterial chemoembolization in advanced HCC patients with main portal vein tumor thrombus. Cancer Imaging 2023; 23(1) doi: 10.1186/s40644-023-00581-8
|
| 21 |
Haohao Lu, Chuansheng Zheng, Bin Liang, Bin Xiong. Efficacy and Safety of Lobaplatin-TACE in the Treatment of Primary Hepatocellular
Carcinoma: A Retrospective Study. Anti-Cancer Agents in Medicinal Chemistry 2023; 23(4): 461 doi: 10.2174/1871520622666220601115458
|
| 22 |
Antonio Facciorusso. Drug-eluting beads transarterial chemoembolization for hepatocellular carcinoma: Current state of the art. World Journal of Gastroenterology 2018; 24(2): 161-169 doi: 10.3748/wjg.v24.i2.161
|
| 23 |
Lunxu Li, Shilin Xia, Xueying Shi, Xu Chen, Dong Shang. The novel immune-related genes predict the prognosis of patients with hepatocellular carcinoma. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-89747-7
|
| 24 |
M. Massani, T. Stecca, C. Ruffolo, N. Bassi. Should we routinely use DEBTACE for unresectable HCC? cTACE versus DEBTACE: a single-center survival analysis. Updates in Surgery 2017; 69(1): 67 doi: 10.1007/s13304-017-0414-3
|
| 25 |
Shao-Hua Lee, Chia-Ying Lin, Ya-Chun Hsu, Yi-Sheng Liu, Ming-Tsung Chuang, Ming-Ching Ou. Comparison of the Efficacy of Two Microsphere Embolic Agents for Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma Patients. Cancer Research and Treatment 2020; 52(1): 24 doi: 10.4143/crt.2019.018
|
| 26 |
Olga Kantor, Marshall S. Baker. Gastrointestinal Malignancies. Cancer Treatment and Research 2016; : 165 doi: 10.1007/978-3-319-34244-3_8
|
| 27 |
Emanuel Eguia, Talia Baker, Marshall Baker. Gastrointestinal Malignancies. Cancer Treatment and Research 2024; 192: 185 doi: 10.1007/978-3-031-61238-1_10
|
| 28 |
Alessandro Granito, Luigi Bolondi. Non-transplant therapies for patients with hepatocellular carcinoma and Child-Pugh-Turcotte class B cirrhosis. The Lancet Oncology 2017; 18(2): e101 doi: 10.1016/S1470-2045(16)30569-1
|
| 29 |
Matteo Renzulli, Nicolò Brandi, Anna Pecorelli, Luigi Vincenzo Pastore, Alessandro Granito, Giuseppe Martinese, Francesco Tovoli, Mario Simonetti, Elton Dajti, Antonio Colecchia, Rita Golfieri. Segmental Distribution of Hepatocellular Carcinoma in Cirrhotic Livers. Diagnostics 2022; 12(4): 834 doi: 10.3390/diagnostics12040834
|
| 30 |
Antonio Facciorusso, Marianna Di Maso, Nicola Muscatiello. Drug-eluting beads versus conventional chemoembolization for the treatment of unresectable hepatocellular carcinoma: A meta-analysis. Digestive and Liver Disease 2016; 48(6): 571 doi: 10.1016/j.dld.2016.02.005
|
| 31 |
Natascha Roehlen, Richard F. Knoop, Katharina Laubner, Jochen Seufert, Henning Schwacha, Robert Thimme, Andreas Fischer. Ischemic Duodenal Ulceration after Transarterial Chemoembolization for Hepatocellular Carcinoma: A Case Report. Case Reports in Gastroenterology 2018; 12(2): 352 doi: 10.1159/000490604
|
| 32 |
Alexander E. Hare, Mina S. Makary. Hepatobiliary Cancers: An Interdisciplinary Approach. Interdisciplinary Cancer Research 2022; 3: 307 doi: 10.1007/16833_2022_42
|
| 33 |
Ying Zhang, Dejian Hu, Shangcong Han, Guowen Yan, Chao Ma, Chen Wei, Miao Yu, Dongmei Li, Yong Sun. Preparation and evaluation of reduction-responsive nano-micelles for miriplatin delivery. Experimental Biology and Medicine 2016; 241(11): 1169 doi: 10.1177/1535370215625473
|
| 34 |
Murtuza Razi, Gu Jianping, He Xu, Mohammed Jameeluddin Ahmed. Conventional versus drug-eluting bead transarterial chemoembolization: A better option for treatment of unresectable hepatocellular carcinoma. Journal of Interventional Medicine 2021; 4(1): 11 doi: 10.1016/j.jimed.2020.10.006
|
| 35 |
Antonio Facciorusso, Rosa Paolillo, Nicola Tartaglia, Daryl Ramai, Babu P. Mohan, Christian Cotsoglou, Saurabh Chandan, Antonio Ambrosi, Irene Bargellini, Matteo Renzulli, Rodolfo Sacco. Efficacy of combined transarterial radioembolization and sorafenib in the treatment of hepatocarcinoma: A meta-analysis. Digestive and Liver Disease 2022; 54(3): 316 doi: 10.1016/j.dld.2021.06.003
|
| 36 |
Dong Ik Cha, Min Woo Lee, Dongho Hyun, Soo Hyun Ahn, Woo Kyoung Jeong, Hyunchul Rhim. Combined Transarterial Chemoembolization and Radiofrequency Ablation for Hepatocellular Carcinoma Infeasible for Ultrasound-Guided Percutaneous Radiofrequency Ablation: A Comparative Study with General Ultrasound-Guided Radiofrequency Ablation Outcomes. Cancers 2023; 15(21): 5193 doi: 10.3390/cancers15215193
|
| 37 |
Antonio Facciorusso, Gaetano Serviddio, Nicola Muscatiello. Transarterial radioembolization <i>vs</i> chemoembolization for hepatocarcinoma patients: A systematic review and meta-analysis. World Journal of Hepatology 2016; 8(18): 770-778 doi: 10.4254/wjh.v8.i18.770
|
| 38 |
William T.N. Culp. Interventional Oncology. Veterinary Clinics of North America: Small Animal Practice 2016; 46(3): 553 doi: 10.1016/j.cvsm.2015.12.010
|
| 39 |
Sung Won Chung, Min Kyung Park, Young Youn Cho, Youngsu Park, Cheol-Hyung Lee, Hyunwoo Oh, Heejoon Jang, Minseok Albert Kim, Sun Woong Kim, Joon Yeul Nam, Yun Bin Lee, Eun Ju Cho, Su Jong Yu, Hyo-Cheol Kim, Yoon Jun Kim, Jin Wook Chung, Jung-Hwan Yoon, Jeong-Hoon Lee. Effectiveness of Transarterial Chemoembolization-First Treatment for Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis. Journal of Hepatocellular Carcinoma 2021; : 587 doi: 10.2147/JHC.S294440
|
| 40 |
Shanmukha Srinivas, Steven C. Rose, Omar Al Jammal, Lee J. Hsieh, Helena D. Rockwell, David P. Duncan, Jeet Minocha, Zachary T. Berman. Boosted-Dose Yttrium-90 Radiation Segmentectomy or Lobectomy for Hepatocellular Carcinoma Refractory to Prior Transarterial Embolization or Chemoembolization: A Single Institution Retrospective Case Series. CardioVascular and Interventional Radiology 2023; 46(4): 460 doi: 10.1007/s00270-023-03388-z
|
| 41 |
Mengdie Zhao, Ping Xiang, Hao Jiang. TransArterial ChemoEmbolization (TACE) with platinum versus anthracyclines for hepatocellular carcinoma: A meta-analysis. International Journal of Surgery 2018; 53: 151 doi: 10.1016/j.ijsu.2018.03.049
|
| 42 |
Julie K. Heimbach, Laura M. Kulik, Richard S. Finn, Claude B. Sirlin, Michael M. Abecassis, Lewis R. Roberts, Andrew X. Zhu, M. Hassan Murad, Jorge A. Marrero. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology 2018; 67(1): 358 doi: 10.1002/hep.29086
|
| 43 |
Matthew P. Lungren, Alexander J. Towbin, Derek J. Roebuck, Eric J. Monroe, Anne E. Gill, Avnesh Thakor, Richard B. Towbin, Anne Marie Cahill, C. Matthew Hawkins. Role of interventional radiology in managing pediatric liver tumors. Pediatric Radiology 2018; 48(4): 555 doi: 10.1007/s00247-018-4068-1
|
| 44 |
Masakazu Hirakawa, Torahiko Yamanouchi, Satoru Tsuruta, Akihiro Inoue, Hidenari Hirata, Keiji Matsumoto, Katsumi Sakamoto, Hironori Sakai, Koshi Mimori, Hiroshi Honda. Midterm Outcomes and Prognostic Factors of Patients Treated Using Microballoon-Occluded Transarterial Chemoembolization with Miriplatin: A Retrospective Study of 37 Cases. Interventional Radiology 2018; 3(3): 97 doi: 10.22575/interventionalradiology.2018-0001
|
| 45 |
Hongwei Zhao, Fuquan Liu, Zhendong Yue, Lei Wang, Zhenhua Fan, Fuliang He. Association of hepatic vein Lipiodol tram-track sign during transcatheter arterial chemoembolization with perioperative death. Journal of International Medical Research 2017; 45(3): 1148 doi: 10.1177/0300060517704141
|
| 46 |
Pi-Yi Chang, Rheun-Chuan Lee, Po-Chin Liang, Yi-Sheng Liu, Vicent P. Chuang, Ding-Kwo Wu, Yu-Fan Cheng, Jen-I. Huang, Hsiuo-Shan Tseng, Chien-Fu Hung, Reng-Hong Wu, Ming-Chih Chern, Hua-Ming Cheng, Chih-Horng Wu, She-Meng Cheng, Chia-Ling Chiang, Huei-Lung Liang. Multidisciplinary Taiwan consensus for the use of conventional TACE in hepatocellular carcinoma treatment. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1186674
|
| 47 |
Katrin Fuchs, Rafael Duran, Alban Denys, Pierre E. Bize, Gerrit Borchard, Olivier Jordan. Drug-eluting embolic microspheres for local drug delivery – State of the art. Journal of Controlled Release 2017; 262: 127 doi: 10.1016/j.jconrel.2017.07.016
|
| 48 |
Abhishek Bansal, Arvind Chaturvedi. Interventional Radiological Management of Hepatocellular Carcinoma. Indian Journal of Medical and Paediatric Oncology 2020; 41(04): 484 doi: 10.4103/ijmpo.ijmpo_256_19
|
| 49 |
Xinhua Zou, Wenzhe Fan, Miao Xue, Jiaping Li. Evaluation of the Benefits of TACE Combined with Sorafenib for Hepatocellular Carcinoma Based on Untreatable TACE (unTACEable) Progression. Cancer Management and Research 2021; : 4013 doi: 10.2147/CMAR.S304591
|
| 50 |
Chenghao Zhao, Zhanwang Xiang, Mingan Li, Haofan Wang, Huan Liu, Huzheng Yan, Mingsheng Huang. Transarterial Chemoembolization Combined with Atezolizumab Plus Bevacizumab or Lenvatinib for Unresectable Hepatocellular Carcinoma: A Propensity Score Matched Study. Journal of Hepatocellular Carcinoma 2023; : 1195 doi: 10.2147/JHC.S418256
|
| 51 |
Pierleone Lucatelli, Renato Argirò, Gianluca De Rubeis, Bianca Rocco, Stefano Ginanni Corradini, Mario Corona, Pier Giorgio Nardis, Luca Saba, Gianluca Mennini, Francesco Fiorentino, Alessandro Corsi, Carlo Catalano, Mario Bezzi. Polyethylene Glycol Epirubicin-Loaded Transcatheter Arterial Chemoembolization Procedures Utilizing a Combined Approach with 100 and 200 μm Microspheres: A Promising Alternative to Current Standards. Journal of Vascular and Interventional Radiology 2019; 30(3): 305 doi: 10.1016/j.jvir.2018.10.026
|
| 52 |
Saahil Islam, Venkatesh N. Murthy, Dominik Neumann, Badhan Kumar Das, Puneet Sharma, Andreas Maier, Dorin Comaniciu, Florin C. Ghesu. Self-supervised learning for interventional image analytics: toward robust device trackers. Journal of Medical Imaging 2024; 11(03) doi: 10.1117/1.JMI.11.3.035001
|
| 53 |
Katharina Kronenberg, Julia Werner, Peter Bohrer, Katja Steiger, Rebecca Buchholz, Maximilian von Bremen-Kühne, Matthias Elinkmann, Philipp M Paprottka, Rickmer F Braren, Fabian K Lohöfer, Uwe Karst. Simultaneous quantification of Gadoxetic acid and Cisplatin in hepatocellular carcinomas using laser ablation–inductively coupled plasma–mass spectrometry. Metallomics 2023; 15(10) doi: 10.1093/mtomcs/mfad052
|
| 54 |
Antonio Facciorusso, Francesco Bellanti, Rosanna Villani, Veronica Salvatore, Nicola Muscatiello, Fabio Piscaglia, Gianluigi Vendemiale, Gaetano Serviddio. Transarterial chemoembolization vs bland embolization in hepatocellular carcinoma: A meta‐analysis of randomized trials. United European Gastroenterology Journal 2017; 5(4): 511 doi: 10.1177/2050640616673516
|
| 55 |
C. L. Chiang, Mark K. H. Chan, Cynthia S. Y. Yeung, Connie H. M. Ho, Francis A. S. Lee, Venus W. Y. Lee, Frank C. S. Wong, Oliver Blanck. Combined stereotactic body radiotherapy and trans-arterial chemoembolization as initial treatment in BCLC stage B–C hepatocellular carcinoma. Strahlentherapie und Onkologie 2019; 195(3): 254 doi: 10.1007/s00066-018-1391-2
|
| 56 |
Bao-Jiang Liu, Song Gao, Xu Zhu, Jian-Hai Guo, Xin Zhang, Hui Chen, Xiao-Dong Wang, Ren-Jie Yang. Sorafenib combined with embolization plus hepatic arterial infusion chemotherapy for inoperable hepatocellular carcinoma. World Journal of Gastrointestinal Oncology 2020; 12(6): 663-676 doi: 10.4251/wjgo.v12.i6.663
|
| 57 |
Priscila Cavedon Fontana, Gabriela Perdomo Coral, Alex Finger Horbe, Raquel de Freitas Jotz, Beatriz Garcia de Morais, Angelo Alves de Mattos. Retrospective analysis of the efficacy and survival associated with cTACE and DEB-TACE in the palliative treatment of hepatocellular carcinoma: experience of a tertiary care hospital in southern Brazil. Radiologia Brasileira 2024; 57 doi: 10.1590/0100-3984.2023.0105
|
| 58 |
Yong Kang Lee, Kyu Sik Jung, Do Young Kim, Jin Young Choi, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Sang Hoon Ahn, Kwang‐Hyub Han, Gyoung Min Kim, Man Deuk Kim, Sung Il Park, Jong Yun Won, Do Yun Lee. Conventional versus drug‐eluting beads chemoembolization for hepatocellular carcinoma: Emphasis on the impact of tumor size. Journal of Gastroenterology and Hepatology 2017; 32(2): 487 doi: 10.1111/jgh.13501
|
| 59 |
Nicolò Brandi, Matteo Renzulli. The Synergistic Effect of Interventional Locoregional Treatments and Immunotherapy for the Treatment of Hepatocellular Carcinoma. International Journal of Molecular Sciences 2023; 24(10): 8598 doi: 10.3390/ijms24108598
|
| 60 |
Pierleone Lucatelli, Gianluca De Rubeis, Fabrizio Basilico, Luca Ginanni Corradini, Mario Corona, Mario Bezzi, Carlo Catalano. Sequential dual-phase cone-beam CT is able to intra-procedurally predict the one-month treatment outcome of multi-focal HCC, in course of degradable starch microsphere TACE. La radiologia medica 2019; 124(12): 1212 doi: 10.1007/s11547-019-01076-y
|
| 61 |
Omkolsoum Alhaddad, Asmaa Gomaa, Merhan El Shamandy, Mohamed Kohla, Ahmed Edrees, Reham Ashour. Evaluation of different scoring systems for repeating Transarterial Chemoembolization in Egyptian patients with Hepatocellular Carcinoma. Romanian Journal of Internal Medicine 2024; doi: 10.2478/rjim-2024-0028
|
| 62 |
Lin Zhou, Lin-Zhi Zhang, Jing-Yan Wang, Yong-Wu Li, Hai-Dong Hu, Xiao-Ming Peng, Yun Zhao, Xi-Ming Wang, Hui Xie, Chun-Zi Liu, Hua-Ming Wang. Perioperative safety analysis of transcatheter arterial chemoembolization for hepatocellular carcinoma patients with preprocedural leukopenia or thrombocytopenia. Molecular and Clinical Oncology 2017; 7(3): 435 doi: 10.3892/mco.2017.1345
|
| 63 |
Nisha Manjunatha, Vinutna Ganduri, Kruthiga Rajasekaran, Shrimahitha Duraiyarasan , Mayowa Adefuye. Transarterial Chemoembolization and Unresectable Hepatocellular Carcinoma: A Narrative Review. Cureus 2022; doi: 10.7759/cureus.28439
|
| 64 |
Michele Barone, Alfredo Di Leo, Carlo Sabbà, Antonio Mazzocca. The perplexity of targeting genetic alterations in hepatocellular carcinoma. Medical Oncology 2020; 37(8) doi: 10.1007/s12032-020-01392-8
|
| 65 |
Delia D’Avola, Alessandro Granito, Manuel de la Torre-Aláez, Fabio Piscaglia. The importance of liver functional reserve in the non-surgical treatment of hepatocellular carcinoma. Journal of Hepatology 2022; 76(5): 1185 doi: 10.1016/j.jhep.2021.11.013
|
| 66 |
Maria Baimas-George, Michael Watson, Jesse Sulzer, Patrick Salibi, Keith J. Murphy, David Levi, John B. Martinie, Dionisios Vrochides, Erin H. Baker, Lee Ocuin, David A. Iannitti. Pathologic response translates to improved patient survival after locoregional treatment for hepatocellular carcinoma: the importance of minimally invasive microwave ablation. Surgical Endoscopy 2021; 35(6): 3122 doi: 10.1007/s00464-020-07747-6
|
| 67 |
Selin Oncul, Gulsah Karakaya, Mutlu Dilsiz Aytemir, Ayse Ercan. A kojic acid derivative promotes intrinsic apoptotic pathway of hepatocellular carcinoma cells without incurring drug resistance. Chemical Biology & Drug Design 2019; 94(6): 2084 doi: 10.1111/cbdd.13615
|
| 68 |
Zhe-Xuan Wang, Jing Li, En-Xin Wang, Dong-Dong Xia, Wei Bai, Qiu-He Wang, Jie Yuan, Xiao-Mei Li, Jing Niu, Zhan-Xin Yin, Jie-Lai Xia, Dai-Ming Fan, Guo-Hong Han. Validation of the six-and-twelve criteria among patients with hepatocellular carcinoma and performance score 1 receiving transarterial chemoembolization. World Journal of Gastroenterology 2020; 26(15): 1805-1819 doi: 10.3748/wjg.v26.i15.1805
|
| 69 |
Soon Young Ko, Won Hyeok Choe. Potential prognostic factors for solitary hepatocellular carcinoma ≤ 5 cm after transarterial chemoembolization. The Korean Journal of Internal Medicine 2019; 34(6): 1210 doi: 10.3904/kjim.2019.344
|
| 70 |
Antonio Facciorusso, Irene Bargellini, Marina Cela, Ivan Cincione, Rodolfo Sacco. Comparison between Y90 Radioembolization Plus Sorafenib and Y90 Radioembolization alone in the Treatment of Hepatocellular Carcinoma: A Propensity Score Analysis. Cancers 2020; 12(4): 897 doi: 10.3390/cancers12040897
|
| 71 |
Iveta Urban, Florian Primavesi, Klaus Bogner, Claudia Bartsch, Marlene Trattner, Alexandra Schmid, Stefan Stättner. Hepatocellular carcinoma—neoadjuvant systemic and local treatment concepts to improve resectability rates and oncological outcome. memo - Magazine of European Medical Oncology 2022; 15(1): 5 doi: 10.1007/s12254-021-00791-5
|